The San Francisco stalwart, which traces its roots to the California Gold Rush, beat Wall Street's earnings expectations in ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.94 billion, finds itself at a critical juncture as it navigates challenges to its flagship Eylea franchise while ...

Related: JP Morgan earnings kick-off bank reporting season as stock market wobbles “Our earnings profile continues to ... FALLON/Getty Images Wells Fargo CEO: bank reached important ...

Mixed signals for Apple Inc. as stagnant growth, bearish trends, and institutional outflows cast shadows over upcoming ...

Large technology companies and industrial manufacturers, which can derive much of their revenue from overseas, are particularly vulnerable to dollar strength. This impact can cascade through the ...

Boston Properties, Inc. (NYSE:BXP), a leading U.S. Real Estate Investment Trust (REIT) specializing in office properties, ...

Meta enjoys key catalysts in the long term, including growth potential with AI. Read why Meta stock may face headwinds on a ...

If the Bruins do opt for a mid-season retool this year, Boston could have several appealing trade chip in place.

Impressive Gross Profit Growth: Despite the challenges, ZK International saw a remarkable 405% surge in gross profit, climbing from $1.3 million in 2023 to $6.5 million in 2024. The gross profit ...

US President Trump threatened to slap 50% tariffs on Colombia imports in a deportation spat over the weekend.

We recently published a list of Jim Cramer is Watching These 8 Stocks. In this article, we are going to take a look at where ...

In the wilds of South Africa’s Northern Cape, poaching ‘green diamonds’ has become an almost irresistible temptation ...